UBE3A and epilepsy: Although the exact mechanisms of how these genes are linked to the mTOR signaling are yet to be clarified, patients with CDKL5, UBE3A, and MECP2 mutations often develop epilepsy and display altered mTOR activity (Sun et al., 2018; Negraes et al., 2021).